Pietro Invernizzi

35.4k total citations · 3 hit papers
344 papers, 14.6k citations indexed

About

Pietro Invernizzi is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Pietro Invernizzi has authored 344 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 225 papers in Hepatology, 192 papers in Epidemiology and 121 papers in Surgery. Recurrent topics in Pietro Invernizzi's work include Liver Diseases and Immunity (208 papers), Liver Disease Diagnosis and Treatment (156 papers) and Pediatric Hepatobiliary Diseases and Treatments (73 papers). Pietro Invernizzi is often cited by papers focused on Liver Diseases and Immunity (208 papers), Liver Disease Diagnosis and Treatment (156 papers) and Pediatric Hepatobiliary Diseases and Treatments (73 papers). Pietro Invernizzi collaborates with scholars based in Italy, United States and United Kingdom. Pietro Invernizzi's co-authors include Mauro Podda, Carlo Selmi, Ana Lleò, M. Eric Gershwin, M. Eric Gershwin, Pier Maria Battezzati, Marco Marzioni, Gideon M. Hirschfield, David Jones and Massimo Zuin and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Pietro Invernizzi

334 papers receiving 14.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

2017 886 citations Gideon M. Hirschfield, Pietro Invernizzi et al. Journal of Hepatology profile →
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development

2019 495 citations Pietro Invernizzi et al. Journal of Hepatology profile →
Exploring the landscape of steatotic liver disease in the general US population

2023 77 citations Marco Carbone, Pietro Invernizzi et al. Liver International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pietro Invernizzi Italy	66	7.6k	6.9k	5.0k	2.2k	2.1k	344	14.6k
Geoffrey W. McCaughan Australia	73	8.7k 1.1×	8.4k 1.2×	5.2k 1.0×	3.4k 1.5×	3.1k 1.4×	528	20.3k
Patrick S.C. Leung United States	62	5.9k 0.8×	4.7k 0.7×	2.6k 0.5×	2.5k 1.1×	1.5k 0.7×	250	11.7k
Giuliano Ramadori Germany	59	4.9k 0.6×	4.0k 0.6×	2.7k 0.5×	1.6k 0.7×	3.1k 1.5×	375	12.3k
Hirohito Tsubouchi Japan	55	5.7k 0.7×	4.4k 0.6×	2.9k 0.6×	1.2k 0.6×	2.1k 1.0×	319	10.5k
John P. Iredale United Kingdom	72	11.0k 1.4×	8.7k 1.3×	5.1k 1.0×	3.9k 1.8×	5.1k 2.4×	176	21.3k
Dimitrios P. Bogdanos Greece	55	3.6k 0.5×	4.0k 0.6×	1.6k 0.3×	2.1k 1.0×	1.4k 0.6×	366	10.1k
Kazuhiko Nakao Japan	48	2.2k 0.3×	2.9k 0.4×	2.2k 0.4×	1.3k 0.6×	2.4k 1.1×	393	9.2k
Stuart J. Knechtle United States	60	4.0k 0.5×	2.5k 0.4×	8.1k 1.6×	3.4k 1.6×	1.2k 0.6×	402	14.4k
Achim Weber Switzerland	55	1.8k 0.2×	2.0k 0.3×	2.1k 0.4×	1.5k 0.7×	2.9k 1.4×	213	9.0k
Norman M. Kneteman Canada	54	4.9k 0.6×	3.6k 0.5×	10.6k 2.1×	1.0k 0.5×	2.9k 1.4×	209	16.3k

Countries citing papers authored by Pietro Invernizzi

Since Specialization

Citations

This map shows the geographic impact of Pietro Invernizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Invernizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Invernizzi more than expected).

Fields of papers citing papers by Pietro Invernizzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pietro Invernizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Invernizzi. The network helps show where Pietro Invernizzi may publish in the future.

Co-authorship network of co-authors of Pietro Invernizzi

This figure shows the co-authorship network connecting the top 25 collaborators of Pietro Invernizzi. A scholar is included among the top collaborators of Pietro Invernizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pietro Invernizzi. Pietro Invernizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abbas, Nadir, Rachel A. Smith, Neil Halliday, et al.. (2025). Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis. Alimentary Pharmacology & Therapeutics. 63(4). 494–506.

Massironi, Sara, Camilla Gallo, Edith Lahner, et al.. (2024). Occurrence and characteristics of endoscopic gastric polyps in patients with autoimmune gastritis (AGAPE study): A multicentric cross-sectional study. Digestive and Liver Disease. 57(1). 198–205. 11 indexed citations

Mulinacci, Giacomo, Lorena Pirola, Davide Ippolito, et al.. (2024). Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study. United European Gastroenterology Journal. 12(5). 562–573. 10 indexed citations

Gerussi, Alessio, Pietro Invernizzi, & Marco Carbone. (2024). Challenges in the diagnosis and management of AIH-PBC syndrome. JHEP Reports. 7(1). 101224–101224. 1 indexed citations

Riva, M, et al.. (2024). The liver in Christian thought: Symbolism, morality, and spirituality. Clinical Liver Disease. 23(1). e0236–e0236. 1 indexed citations

Rossi, A., et al.. (2024). Hepatotoxicity in Cancer Immunotherapy: Diagnosis, Management, and Future Perspectives. Cancers. 17(1). 76–76. 3 indexed citations

Invernizzi, Pietro, Marco Carbone, David Jones, et al.. (2023). Setanaxib, a first‐in‐class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo‐controlled, phase 2 trial. Liver International. 43(7). 1507–1522. 37 indexed citations

Massironi, Sara, Giacomo Mulinacci, Camilla Gallo, et al.. (2023). Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms. Cells. 12(20). 2473–2473. 24 indexed citations

Elvevi, Alessandra, et al.. (2023). Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies?. World Journal of Hepatology. 15(12). 1284–1293. 2 indexed citations

10.

Elvevi, Alessandra, et al.. (2023). Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review. Cells. 12(3). 370–370. 25 indexed citations

11.

Gerussi, Alessio, Elvezia Maria Paraboschi, Claudio Cappadona, et al.. (2022). The Role of Epigenetics in Primary Biliary Cholangitis. International Journal of Molecular Sciences. 23(9). 4873–4873. 16 indexed citations

12.

Pastore, Mirella, Giulia Lori, Alessandra Gentilini, et al.. (2020). Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives. Cells. 9(3). 596–596. 18 indexed citations

13.

Meadows, Vik, Lindsey Kennedy, Laura Hargrove, et al.. (2019). Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2−/− mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(12). 165557–165557. 30 indexed citations

14.

Bernuzzi, Francesca, Francesco Marabita, Ana Lleò, et al.. (2016). Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. Clinical & Experimental Immunology. 185(1). 61–71. 70 indexed citations

15.

Liberal, Rodrigo, Ynto S. de Boer, Raúl J. Andrade, et al.. (2016). Expert clinical management of autoimmune hepatitis in the real world. Alimentary Pharmacology & Therapeutics. 45(5). 723–732. 60 indexed citations

16.

Castronovo, Chiara, Raffaella Rossetti, Maria Paola Recalcati, et al.. (2013). Gene dosage as a relevant mechanism contributing to the determination of ovarian function in Turner syndrome. Human Reproduction. 29(2). 368–379. 47 indexed citations

17.

Longhi, Maria Serena, Dimitrios P. Bogdanos, Pietro Invernizzi, et al.. (2009). 676 FINE SPECIFICITY OF ANTI-NUP62 T-HELPER 1 CELL (TH1) IMMUNE RESPONSE IN PRIMARY BILIARY CIRRHOSIS. Journal of Hepatology. 50. S248–S248. 1 indexed citations

18.

Alpini, Gianfranco, Pietro Invernizzi, Eugenio Gaudio, et al.. (2008). Serotonin Metabolism Is Dysregulated in Cholangiocarcinoma, which Has Implications for Tumor Growth. Cancer Research. 68(22). 9184–9193. 93 indexed citations

19.

Ceni, E., Tommaso Mello, Mirko Tarocchi, et al.. (2005). Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells. Florence Research (University of Florence). 1 indexed citations

20.

Invernizzi, Pietro, Maria Luisa Biondi, Pier Maria Battezzati, et al.. (2002). Presence of fetal DNA in maternal plasma decades after pregnancy. Human Genetics. 110(6). 587–591. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact